中华实验外科杂志
中華實驗外科雜誌
중화실험외과잡지
CHINESE JOURNAL OF EXPERIMENTAL SURGERY
2011年
6期
837-840
,共4页
王志华%曾星%胡志全%叶章群%王冀%李有元%刘双林%鲁海洋%邓康俐
王誌華%曾星%鬍誌全%葉章群%王冀%李有元%劉雙林%魯海洋%鄧康俐
왕지화%증성%호지전%협장군%왕기%리유원%류쌍림%로해양%산강리
bcl-2%反义寡核苷酸%膀胱癌
bcl-2%反義寡覈苷痠%膀胱癌
bcl-2%반의과핵감산%방광암
bcl-2%Antisense oligodeoxynucleotides%Bladder carcinoma
目的 观察bcl-2反义寡核苷酸对膀胱癌顺铂(DDP)耐药细胞耐药性的逆转并增强其敏感性的作用.方法 以膀胱癌顺铂耐药细胞株BIU87/DDP为模型,用脂质体转染和电转染的方法,将bcl-2反义寡核苷酸(bcl-2-AODN)转染BIU87/DDP细胞,同时以转染bcl-2正义链(bel-2-SODN)及RPMI 1640作对照.采用DNA凝胶电泳检测转染后是否诱导细胞凋亡,应用免疫组织化学技术检测bcl-2蛋白表达变化,逆转录-聚合酶链反应(RT-PCR)检测bcl-2 mRNA表达水平的变化.噻唑蓝(MTY)比色法检测细胞抑制率与药物半数抑制浓度(IC50).结果 转染AODN的细胞IC50值(20.400 ±2.590)mg/L,较未转染耐药细胞(66.000±4.637)mg/L,差异有统计学意义(P<0.05);脂质体转染bcl-2反义寡核苷酸12 h后,倒置显微镜下即可见BIU87/DDP有30%细胞出现变化(但不能分辨死亡或凋亡),DNA凝胶电泳出现明显的DNA梯带状条带,对照组无变化.采用电穿孔转染48 h后,细胞在倒置显微镜下的变化不明显,以顺铂10mg/L作用于转染细胞24 h,分别收集细胞检测.bcl-2蛋白表达降低;实验组BIU87/DDP+AODN细胞bcl-2 mRNA表达(0.72 ±0.07)与转染前(2.94±0.09)比较,mRNA表达率下降(P<0.05).结论 bcl-2反义寡核苷酸可通过增加细胞的凋亡而一定程度地逆转膀胱癌细胞的顺铂耐药性,提高膀胱癌细胞对化学治疗药物的敏感性.
目的 觀察bcl-2反義寡覈苷痠對膀胱癌順鉑(DDP)耐藥細胞耐藥性的逆轉併增彊其敏感性的作用.方法 以膀胱癌順鉑耐藥細胞株BIU87/DDP為模型,用脂質體轉染和電轉染的方法,將bcl-2反義寡覈苷痠(bcl-2-AODN)轉染BIU87/DDP細胞,同時以轉染bcl-2正義鏈(bel-2-SODN)及RPMI 1640作對照.採用DNA凝膠電泳檢測轉染後是否誘導細胞凋亡,應用免疫組織化學技術檢測bcl-2蛋白錶達變化,逆轉錄-聚閤酶鏈反應(RT-PCR)檢測bcl-2 mRNA錶達水平的變化.噻唑藍(MTY)比色法檢測細胞抑製率與藥物半數抑製濃度(IC50).結果 轉染AODN的細胞IC50值(20.400 ±2.590)mg/L,較未轉染耐藥細胞(66.000±4.637)mg/L,差異有統計學意義(P<0.05);脂質體轉染bcl-2反義寡覈苷痠12 h後,倒置顯微鏡下即可見BIU87/DDP有30%細胞齣現變化(但不能分辨死亡或凋亡),DNA凝膠電泳齣現明顯的DNA梯帶狀條帶,對照組無變化.採用電穿孔轉染48 h後,細胞在倒置顯微鏡下的變化不明顯,以順鉑10mg/L作用于轉染細胞24 h,分彆收集細胞檢測.bcl-2蛋白錶達降低;實驗組BIU87/DDP+AODN細胞bcl-2 mRNA錶達(0.72 ±0.07)與轉染前(2.94±0.09)比較,mRNA錶達率下降(P<0.05).結論 bcl-2反義寡覈苷痠可通過增加細胞的凋亡而一定程度地逆轉膀胱癌細胞的順鉑耐藥性,提高膀胱癌細胞對化學治療藥物的敏感性.
목적 관찰bcl-2반의과핵감산대방광암순박(DDP)내약세포내약성적역전병증강기민감성적작용.방법 이방광암순박내약세포주BIU87/DDP위모형,용지질체전염화전전염적방법,장bcl-2반의과핵감산(bcl-2-AODN)전염BIU87/DDP세포,동시이전염bcl-2정의련(bel-2-SODN)급RPMI 1640작대조.채용DNA응효전영검측전염후시부유도세포조망,응용면역조직화학기술검측bcl-2단백표체변화,역전록-취합매련반응(RT-PCR)검측bcl-2 mRNA표체수평적변화.새서람(MTY)비색법검측세포억제솔여약물반수억제농도(IC50).결과 전염AODN적세포IC50치(20.400 ±2.590)mg/L,교미전염내약세포(66.000±4.637)mg/L,차이유통계학의의(P<0.05);지질체전염bcl-2반의과핵감산12 h후,도치현미경하즉가견BIU87/DDP유30%세포출현변화(단불능분변사망혹조망),DNA응효전영출현명현적DNA제대상조대,대조조무변화.채용전천공전염48 h후,세포재도치현미경하적변화불명현,이순박10mg/L작용우전염세포24 h,분별수집세포검측.bcl-2단백표체강저;실험조BIU87/DDP+AODN세포bcl-2 mRNA표체(0.72 ±0.07)여전염전(2.94±0.09)비교,mRNA표체솔하강(P<0.05).결론 bcl-2반의과핵감산가통과증가세포적조망이일정정도지역전방광암세포적순박내약성,제고방광암세포대화학치료약물적민감성.
Objective To observe the influence of bcl-2 antisense oligodeoxynucleotides (ASON)on reversal of cisplatin resistance in BIU87 cell line of bladder carcinoma. Methods Cisplatin resistance bladder carcinoma cells served as models. The bcl-2 antisense oligodeoxynucleotides were transfected to the cells by lipofectamine and electroporation. The sense-and random-oligodeoxynucleotides were used as controls. The expression level of bcl-2 mRNA was detected by using semi-quantitative reverse transcription polymerase chain reaction ( RT-PCR) . The apoptosis of bladder cancer cell lines was examined by DNA ladder assay. The protein level and 50% inhibitory concentration (IC50) were measured by immunofluorescence technique and methyl thiazol tetrazolium (MTT) assay, respectively. Results Transfecting BIU87/DDP cells with antisense oligonucleotides statistically reduced IC50, values of BID/DDP cells from (66. 000 ±4. 637) to (20. 400 ±2. 590) mg/L. Twelve h after transfection by lipofectamine, 30% cells had apoptotic or necrotic changes under the inverted phase contrast microscopy, and DNA " Ladder" was observed with agrose gel electrophoresis in the antisense-transfected cells. Forty-eight h after transfection by electroporation followed by treatment of 10 mg/L cisplatin, RT-PCR showed the expression of bcl-2 mRNA in the transfected cells was significantly lower (0. 72 ± 0. 07 ) than before transfection ( 2. 94 ± 0. 09 ) , and that of bcl-2 protein was decreased, as well as the IC50. Conclusion bcl-2 antisense oligodeoxynucleotides can reverse the resistance to cisplatin in BIU87/DDP cells by inhibiting the expression of bcl-2 protein and increasing the apoptosis.